Loading data
MEDSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 23.34 m USD | 18.13 m USD | — |
| Cost of revenue | 29.76 m USD | 16.36 m USD | — |
| Gross profit | -6.43 m USD | 1.77 m USD | — |
| Operating profit | -93.75 m USD | -6.15 m USD | -2.88 m USD |
| Profit before tax | -101.27 m USD | -6.86 m USD | -2.9 m USD |
| Net income (reported basis) | -101.27 m USD | -6.86 m USD | -2.9 m USD |
| Basic earnings per share | -1.43 USD/share | -0.15 USD/share | -0.06 USD/share |
| Diluted earnings per share | -1.43 USD/share | -0.15 USD/share | -0.06 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.